ArticleMaterials today. Proceedings2023
The artificial intelligence (AI) role for tackling against COVID-19 pandemic.
Article in Materials today. Proceedings, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Innovation through Artificial Intelligence in Triage Systems for Resource Optimization in Future Pandemics.Biomimetics (Basel, Switzerland) · 2024Article
- A Deep Learning Model for the Diagnosis and Discrimination of Gram-Positive and Gram-Negative Bacterial Pneumonia for Children Using Chest Radiography Images and Clinical Information.Infection and drug resistance · 2023Article
- The prospective of Artificial Intelligence in COVID-19 Pandemic.Health and technology · 2021Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
COVID-19 gains from the research and technology component's establishment of information science, artificial intelligence, and computer understanding. The article aims to discuss the numerous facets of today's modern technology utilized to combat COVID-19 emergencies on various scales, such as medicinal picture handling, illness tracking, expected outcomes, computational science, and medications. Techniques: A complex search of the knowledge base associated with existing COVID-19 innovation is conducted. Furthermore, a concise survey of the excluded data is conducted, analyzing the various aspects of current developments for dealing with the COVID-19 pandemic. The below are the outcomes: We have a window of musings on the audit of the tech propellers used to mitigate and mask the significant impact of the upheaval. Even though several investigations into current innovation in COVID-19 have surfaced, there are still required implementations and contributions of innovation in this war. Consequently, a thorough presentation of the available data is given, and several modern technology implementations for combating the pandemic of COVID-19. Continuous advancements of advanced technologies have aided in improving the public's lives, and there is a strong belief that proven study plans utilizing AI would be of great benefit in assisting people in combating this infection.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.